{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T21:43:13Z","timestamp":1744839793312,"version":"3.27.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":132,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1002\/hep.27824","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T19:42:56Z","timestamp":1427917376000},"page":"346-348","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Inhibition of immune tolerance unmasks drug\u2010induced allergic hepatitis"],"prefix":"10.1097","volume":"62","author":[{"given":"Jack","family":"Uetrecht","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences,University of Toronto,Toronto,Ontario,Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Kaplowitz","sequence":"additional","affiliation":[{"name":"USC Research Center for Liver Disease,Keck School of Medicine of USC, University of Southern California,Los Angeles,CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2015,4,22]]},"reference":[{"key":"hep27824-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.86.1.322","article-title":"Human anti\u2010endoplasmic reticulum antibodies in sera of patients with halothane\u2010induced hepatitis are directed against a trifluoroacetylated carboxylesterase","volume":"86","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"hep27824-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-398339-8.00003-3","article-title":"Animal models of idiosyncratic drug reactions","volume":"63","year":"2012","journal-title":"Adv Pharmacol"},{"key":"hep27824-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genome\u2010wide study identifies HLA alleles associated with lumiracoxib\u2010related liver injury","volume":"42","year":"2010","journal-title":"Nat Genet"},{"key":"hep27824-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.27764","article-title":"Drug\u2010induced allergic hepatitis develops in mice when myeloid\u2010derived suppressor cells are depleted prior to halothane treatment.","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"hep27824-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.27549","article-title":"Treatment of PD\u20101 mice with amodiaquine and anti\u2010CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"hep27824-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/tx960083q","article-title":"Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis","volume":"9","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"hep27824-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26564","article-title":"Acute Liver Study Group. Detection of anti\u2010isoniazid and anti\u2010cytochrome P450 antibodies in patients with isoniazid\u2010induced liver failure","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"hep27824-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jhep.2008.03.017","article-title":"Analysis of IL\u201010, IL\u20104 and TNF\u2010alpha polymorphisms in drug\u2010induced liver injury (DILI) and its outcome","volume":"49","year":"2008","journal-title":"J Hepatol"},{"key":"hep27824-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA\u2010B*5701 genotype is a major determinant of drug\u2010induced liver injury due to flucloxacillin","volume":"41","year":"2009","journal-title":"Nat Genet"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27824","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201508000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T01:01:58Z","timestamp":1729213318000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201508000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,22]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27824","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"type":"print","value":"0270-9139"},{"type":"electronic","value":"1527-3350"}],"subject":[],"published":{"date-parts":[[2015,4,22]]},"assertion":[{"value":"2015-03-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-03-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}